Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
April's full moon decides the date of Easter — here's how it works - 2FDA updates risk classification for voluntary shredded cheese recall
- 3Eating Brie, Gouda, cheddar may lower dementia risk, new study says
- 4Why do people have baby teeth and adult teeth?
- 5Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- Norovirus infections increase significantly, with positive test rates reaching 14%
- Fundamental Venture The board Apparatuses for Remote Groups
- Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- Pilot captures jaw-dropping northern lights show from 36,000 feet (photos)
- Flourishing in a Remote Workplace: Individual Techniques
- Astonishing Deserts All over The Planet You Really want To Visit
- Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home
- NASA probe captures stunning photos of Earth and moon on the way to infamous asteroid Apophis
- Investigating the Financial History of the World: A Succinct Outline
